These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20646645)

  • 1. [New index of using serum sodium and potassium and urine sodium and potassium jointly in screening primary aldosteronism in hypertensive patients].
    Yin GS; Zhang SL; Yan L; Li F; Qi YQ; Chen ZC; Cheng H
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):962-6. PubMed ID: 20646645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism.
    Willenberg HS; Kolentini C; Quinkler M; Cupisti K; Krausch M; Schott M; Scherbaum WA
    Eur J Clin Invest; 2009 Jan; 39(1):43-50. PubMed ID: 19067735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of serum sodium to urinary sodium divided by (serum potassium)² to urinary potassium as a screening tool for primary aldosteronism.
    Steichen O; Blanchard A; Plouin PF
    Eur J Clin Invest; 2011 Feb; 41(2):189-94. PubMed ID: 20955208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of reference values for endocrine tests. III: Primary aldosteronism.
    Baas SJ; Endert E; Fliers E; Prummel MF; Wiersinga WM
    Neth J Med; 2003 Feb; 61(2):37-43. PubMed ID: 12735419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining body mass index and serum potassium to urine potassium clearance ratio is an alternative method to predict primary aldosteronism.
    Kuo CC; Wu VC; Tsai CW; Huang KH; Wang SM; Li BC; Chang CC; Lu CC; Yang WS; Chao CT; Tsai IC; Lai CF; Lin WC; Wu MS; Lin YH; Lin CY; Chang HW; Wang WJ; Chiang WC; Kao TW; Chueh SC; Chu TS; Tsai TJ; Wu KD;
    Clin Chim Acta; 2011 Aug; 412(17-18):1637-42. PubMed ID: 21621528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.
    Yin G; Zhang S; Yan L; Wu M; Xu M; Li F; Cheng H
    Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):388-94. PubMed ID: 22689101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone-Mediated Sodium Retention Is Reflected by the Serum Sodium to Urinary Sodium to (Serum Potassium)
    Kanaan E; Haase M; Vonend O; Reincke M; Schott M; Willenberg HS
    Diagnostics (Basel); 2020 Jul; 10(8):. PubMed ID: 32751768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of the fludrocortisone test: duration, NaCl supplementation and cut-off limits for aldosterone.
    Westerdahl C; Bergenfelz A; Larsson J; Nerbrand C; Valdemarsson S; Wihl A; Isaksson A
    Scand J Clin Lab Invest; 2009; 69(2):234-41. PubMed ID: 18951242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
    Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
    J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism.
    Pizzolo F; Raffaelli R; Memmo A; Chiecchi L; Pavan C; Guarini P; Guidi GC; Franchi M; Corrocher R; Olivieri O
    J Hypertens; 2010 Jan; 28(1):135-42. PubMed ID: 19952782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?
    Juutilainen AM; Voutilainen ET; Mykkänen L; Niskanen L
    Blood Press; 2005; 14(4):245-50. PubMed ID: 16126559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the ratio of plasma aldosterone to rennin concentration measured by an automated chemiluminescent immunoassay in screening for primary aldosteronism].
    Song Y; He W; Yang S; Cheng Q; Hu J; Zhen Q; Long J; Feng Z; Li R; Wang Z; Ren W; Zhou B; Li Q
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):6-10. PubMed ID: 26796645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
    Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
    J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.